TGFB1 and breast cancer: Thus, while maternal obesity does not increase FOXP3 levels in the offspring’s mammary tumors, upregulation of Tgfβ1 and VEGFR2 suggests that maternal HFD may promote immunosuppression in TAM-treated offspring’s mammary tumors.